CHRU, Montpellier, France; Inserm, U1061, Montpellier, France; Université Montpellier, France.
Inserm, U1061, Montpellier, France; Université Montpellier, France.
Eur Neuropsychopharmacol. 2014 Oct;24(10):1650-8. doi: 10.1016/j.euroneuro.2014.07.007. Epub 2014 Jul 21.
Only a few studies have investigated the factors associated with suicidal behavior after antidepressant treatment onset in adults. We examined the specific predictors of de novo suicidal ideas or attempts among depressed patients in the community, including subjects potentially at risk of suicidal behaviors, who initiated a new antidepressant treatment.
A large set of GPs and psychiatrists throughout France followed-up, for 6 weeks, 4357 outpatients for whom an antidepressant drug was prescribed. Dimensions related with antidepressant-induced suicidal events, such as depression, anxiety or hopelessness, were assessed longitudinally using univariate and multivariate approaches among subjects with treatment-emergent suicide ideation or attempts.
New suicidal ideas were observed in 9% of patients with no suicidal ideation at baseline (n=81), while suicidal attempts were reported for 1.7% of the sample during the 6-week observation period (n=75). The onset of suicidal ideas and attempts was associated with the initial features of the patients (baseline level of anxiety, past history of suicide attempts and alcohol misuse) and the non-improvement of depression. Worsening of depressive symptoms during the follow-up increased the onset of new suicidal ideas (OR=5.67, p<0.001) and attempts (OR=2.60, p=0.002), corresponding to 67.5% and 56.5% of attributable risk respectively.
When the analyses are restricted to the occurrence of suicidal ideas or attempts, the link between antidepressants and suicide risk might be more adequately explained by a poor response to antidepressant treatment rather than by a direct trigger-effect. This naturalistic study is limited by the use of non-structured diagnoses and self-report outcomes.
仅有少数研究调查了与成年人开始抗抑郁治疗后自杀行为相关的因素。我们检查了社区中抑郁患者新出现自杀想法或尝试的具体预测因素,包括可能有自杀行为风险的受试者,他们开始新的抗抑郁治疗。
法国各地的一大批全科医生和精神科医生对 4357 名接受抗抑郁药物治疗的门诊患者进行了为期 6 周的随访。使用单变量和多变量方法,在出现治疗中出现自杀想法或尝试的患者中,纵向评估与抗抑郁药引起的自杀事件相关的维度,如抑郁、焦虑或绝望。
在基线时没有自杀想法的患者中,有 9%出现了新的自杀想法(n=81),而在 6 周观察期间,有 1.7%的患者报告了自杀尝试(n=75)。自杀想法和尝试的出现与患者的初始特征(基线焦虑水平、自杀尝试的既往史和酒精滥用)和抑郁的改善情况有关。随访期间抑郁症状的恶化增加了新出现自杀想法(OR=5.67,p<0.001)和尝试(OR=2.60,p=0.002)的风险,分别对应于 67.5%和 56.5%的归因风险。
当分析仅限于自杀想法或尝试的发生时,抗抑郁药与自杀风险之间的联系可能更能通过抗抑郁治疗反应不良而不是直接的触发效应来解释。这项自然主义研究受到使用非结构化诊断和自我报告结果的限制。